Therefore, PLCE1 is an effective candidate biomarker and a potential therapeutic target in ESCC because it can restore cell sensitivity to apoptosis or induce apoptosis to eliminate cancer cells. This evidence concerns the gene PLCE1 and esophageal squamous cell carcinoma.